A role for eosinophils in atopic dermatitis

Journal of the American Academy of Dermatology

Volumn 45, Issue 1 SUPPL. 1, 2001, Pages

  Leiferman, Kristin M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC REACTION; ATOPIC DERMATITIS; CELL DEATH; CELL FATE; CELL MIGRATION; CONFERENCE PAPER; DISEASE ASSOCIATION; EOSINOPHIL; EOSINOPHILIA; INFLAMMATION; PRIORITY JOURNAL; SKIN DISEASE;

EID: 0034918977     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.117022     Document Type: Conference Paper

References (37)

1. Atopic dermatitis
2. Eosinophils in atopic dermatitis
3. The role of eosinophils in atopic dermatitis
4. Eosinophils
5. Eosinophil-associated diseases
6. Mechanisms of eosinophil-associated inflammation
7. Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia
8. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis: Comparison with onchocerciasis
9. Diagnostic features of atopic dermatitis
10. Varied density of eosinophils in patients with atopic dermatitis reflecting treatment with anti-allergic drug
11. The role of eosinophils in the pathogenesis of atopic dermatitis: Eosinophil granule proteins as markers of disease activity
12. Assessment of eosinophil and neutrophil participation in atopic dermatitis: Comparison with the IgE-mediated late phase reaction
13. Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes
14. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis
15. Significance of elevated serum LDH (lactate dehydrogenase) activity in atopic dermatitis
16. Blood eosinophilia in atopic dermatitis
17. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis
18. Changes of ECP values, number of eosinophils and EG2 eosinophils in the peripheral blood following oral ketotifen in patients with atopic dermatitis
19. The role of food allergy and eosinophils in atopic dermatitis
20. Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels
21. Long-term therapy with recombinant interferon-gamma (rIFN-gamma) for atopic dermatitis
22. Serum eosinophil cationic protein in patients with atopic dermatitis
23. Eosinophilic cationic protein (ECP) in skin disorders
24. Eosinophil cationic protein in sera of patients with atopic dermatitis
25. Eosinophil cationic protein in atopic eczema
26. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis
27. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis
28. Eosinophil cationic protein in peripheral blood of pediatric patients with allergic diseases
29. Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein
30. Serum levels of eosinophil cationic protein reflect the state of in vitro degranulation of blood hypodense eosinophils in atopic dermatitis
31. Modulation of serum eosinophil cationic protein levels by cyclosporin in severe atopic dermatitis
32. Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood
33. High-dose UVA1 therapy for atopic dermatitis: Results of a multicenter trial
34. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction
35. Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration
36. Delayed eosinophil programmed cell death in vitro: A common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis
37. Corticosteroid-induced apoptosis of eosinophils in atopic dermatitis patients